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Abstract: Clostridium perfringens uses its large arsenal of protein toxins to produce histotoxic,
neurologic and intestinal infections in humans and animals. The major toxins involved in diseases are
alpha (CPA), beta (CPB), epsilon (ETX), iota (ITX), enterotoxin (CPE), and necrotic B-like (NetB) toxins.
CPA is the main virulence factor involved in gas gangrene in humans, whereas its role in animal
diseases is limited and controversial. CPB is responsible for necrotizing enteritis and enterotoxemia,
mostly in neonatal individuals of many animal species, including humans. ETX is the main toxin
involved in enterotoxemia of sheep and goats. ITX has been implicated in cases of enteritis in rabbits
and other animal species; however, its specific role in causing disease has not been proved. CPE is
responsible for human food-poisoning and non-foodborne C. perfringens-mediated diarrhea. NetB is
the cause of necrotic enteritis in chickens. In most cases, host–toxin interaction starts on the plasma
membrane of target cells via specific receptors, resulting in the activation of intracellular pathways
with a variety of effects, commonly including cell death. In general, the molecular mechanisms of cell
death associated with C. perfringens toxins involve features of apoptosis, necrosis and/or necroptosis.
Keywords: Clostridium perfringens; toxins; mechanisms; cell death; apoptosis; necrosis
Key Contribution: This review summarizes current knowledge of Clostridium perfringens toxins
action on target tissues and cells. There is a special emphasis on cell death pathways activated by
these toxins.
1. Introduction
The ability of Clostridium perfringens to produce a large repertoire of toxins makes it a serious
pathogen of humans and animals, being able to produce histotoxic, enteric and/or enterotoxemic
diseases [1,2]. Toxin production varies significantly among C. perfringens strains, which is the basis
for a classification system that was traditionally based upon the presence of encoding genes for alpha
(CPA), beta (CPB), epsilon (ETX) and iota (ITX) toxins [1]. This typing system, however, was recently
revised to include two additional types, i.e., C. perfringens type F strains producing enterotoxin (CPE)
but not CPB, ETX or ITX, and C. perfringens type G strains producing necrotic enteritis B-like toxin
(NetB) [3] (Table 1).
The cellular action of many C. perfringens toxins involves initial binding to a receptor located on
the plasma membrane of target cells, followed by activation of intracellular pathways and a variety
of cytopathic effects that eventually lead to cell death [1,4]. Recent studies of pathogen-induced host
cell death have revealed a variety of complex mechanisms involved in this outcome, once believed
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to be simple and merely incidental [5–7]. Beyond the classic concepts of necrosis (an accidental
and uncontrolled type of cell death) and apoptosis (a programmed mechanism of cell death), it is
now well known that many pathogens are capable of triggering several other pathways which have
been extensively reviewed [8–11]. These include necroptosis (or “programed necrosis”), autophagy,
pyroptosis, anoikis, and several others. Understanding the mechanisms of action and factors needed
for a pathogen to kill host cells is critical to deciphering bacterial pathogenesis, and it represents a key
piece of knowledge to explore novel therapeutic approaches. Here we review the current knowledge
on the mechanisms of action of C. perfringens toxins, with special emphasis on their effects on cell death.
Table 1. Revised classification system of Clostridium perfringens based on the production of six major
toxins [3].
Type
Toxin Produced
α (CPA) β (CPB) ε (ETX) ι (ITX) CPE NetB
A + − − − − −
B + + + − − −
C + + − − +/− −
D + − + − +/− −
E + − − + +/− −
F + − − − + −
G + − − − − +
2. C. perfringens Alpha Toxin (CPA)
2.1. Toxin Genetics, Structure and Role in Disease
The gene encoding CPA is situated in a stable region within the bacterial chromosome and it
is present in all C. perfringens isolates [1,12]. CPA is a zinc metalloenzyme composed of 370 amino
acids, which binds to host cell membranes in the presence of calcium ions [13]. It is divided into two
main domains: the catalytic N-domain and the membrane binding C-domain [13,14]. Only the latter is
immunoprotective [1]. CPA also has a central loop domain containing a ganglioside (GM1a) binding
site [14].
The lethal, hemolytic, and dermonecrotic CPA is the most important virulence factor involved in
human gas gangrene (clostridial myonecrosis) [15] which is characterized by necrosis of skeletal muscle,
subcutaneous edema and emphysema, shock, multiple organ failure and death [16,17]. In addition,
a member of the cholesterol-dependent cytolysin family of pore-forming toxins, named Perfringolysin
O (PFO) [18], has been shown to act synergistically with CPA to produce the pathological effects
observed in gas gangrene [19]. The role of PFO by itself in the disease, however, seems to be minor [1].
Although C. perfringens type A has been associated with cases of gas gangrene in animals, the role of
CPA in these species has not been established [4].
2.2. General Mechanism of Action
The activity of CPA is highly complex, and it varies among cell types due to factors such as the
ratio of phosphatidylcholine (PC) to sphingomyelin (SM) in the plasma membrane, and it is also
influenced by local toxin concentrations. For these reasons, many different pathways are affected
during CPA action (Figure 1). CPA hydrolyzes PC and SM in the plasma membrane, producing
diacylglycerol (DAG) and ceramide (CER), respectively [14]. In addition to these activities, CPA can
indirectly activate endogenous host enzymes which have similar phospholipase and sphingomyelinase
properties through the interaction with Gi type GTP-binding proteins (Gi-GTP-BPs) (Figure 1) [20].
However, CPA action is not limited only to membrane disruption. The ganglioside-binding site of the
toxin in the central loop domain promotes the interaction and tethering of tropomyosin receptor kinase
A (TrkA) on cell membranes [21], leading to activation of the MEK/ERK pathway [14]. Interestingly,
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ganglioside-deficient DonQ or GM95 cells are highly sensitive to CPA action [22–24]. Gangliosides
are glycosphingolipids that may reduce the fluidity of the plasma membrane, resulting in a tighter
packing of phospholipids, and are also associated with electrostatic changes affecting the availability
of substrates [22,25]. These effects could interfere with the membrane-disrupting activity of CPA,
thus protecting cells from cell damage. Sialic acids are important in the structure of gangliosides [26],
and their removal by C. perfringens sialidases increased cell sensitivity to CPA in vitro and in vivo [22],
implying a potential synergism between CPA and sialidases. This synergistic effect of sialidases has
also been proved to increase binding/activity of other C. perfringens toxins (particularly NanI sialidase)
including CPB, CPE and ETX [27,28].
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and PKCθ phosphorylation, resulting in activation of the MEK/ERK signaling cascade and NF-κB, 
which is involved in reactive oxygen species (ROS) and IL-8 formation. A dashed red arrow 
represents what is concluded and/or suggested by the current authors. 
As mentioned before, CPA can bind to and act on membrane PC and SM, in addition to 
activating Gi-GTP-BPs, triggering different pathways depending on the cell type involved (Figure 1). 
For instance, horse erythrocytes are lysed by intrinsic CPA phospholipase activity on PC, and 
probably also through activation of endogenous phosphatidylinositol-specific phospholipase C (PI-
PLC) [29], whereas sheep erythrocytes which contain only traces of PC are affected by CPA mainly 
by activation of the SM metabolism via GTP-BPs [20,30]. In rabbit neutrophils and DonQ cells, CPA-
induced superoxide anion generation occurs through the activation of endogenous phospholipase C 
(PLC) and phosphorylation of PI3K via TrkA receptor, and further phosphorylation of PDK1, PKCθ, 
the MEK1/2, ERK1/2 system and NF-κB [31,32]. This pathway is also important in the generation of 
IL-8 by A549 cells, in addition to the activation of p38 MAPK, which is believed to stabilize IL-8 
mRNA [21]. In this regard, the scarcity of neutrophils within gas gangrene-affected tissues and their 
accumulation on the vascular endothelium could be due, at least in part, to the effect of elevated IL-
8 promoting firm adhesion of neutrophils to extracellular matrix proteins [21]. Recent studies have 
also reported impaired differentiation and replenishment of neutrophils in peripheral blood induced 
by CPA [33], effects that have been attributed to alterations in GM1a-containing lipid rafts in those 
cells [34]. Furthermore, the persistence of an anaerobic microenvironment during gas gangrene is 
Figure 1. Intracellular pathways involved in C. perfringens alpha-toxin (CPA) intracellular action.
Note the binding C-domain (C), catalytic N-domain (N) and ganglioside-binding loop domain (L)
of CPA (PDB ID: 1CA1). CPA directly hydrolyzes phosphatidylcholine (PC) and sphingomyelin
(SM) present in the plasma membrane of target cells. CPA can also activate Gi-type GTP-binding
protein (Gi-GTP-BP) present in the plasma membrane, which in turn will activate endogenous
phospholipases (PI-PLC) and sphingomyelinas s (SMase). Phospholipase activity results in the
formation of diacylglycerol (DAG), and inositol trisphosphate (IP3); the latter mobilizes a d increases
intracytoplasmic calcium ions (iCa2+). Sphingomyelinase action results in ceramide (CER), sphingosine
(SPH) and sphingosine-1-phosphate (S1P) formation. In addition, interaction of CPA with the TrkA
receptor leads to PDK1 and PKCθ phosphorylation, resulting in activation of the MEK/ERK signaling
cascade and NF-κB, which is involved in reactive oxygen species (ROS) and IL-8 formation. A dashed
red arrow represents what is concluded and/or suggested by the current authors.
As mentioned before, CPA can bind to and act on membrane PC and SM, in addition to activating
Gi-GTP-BPs, triggering different pathways d pending on the cell type involved (Figure 1). For instance,
horse erythrocytes are lys d by int insic CPA phospholipase activity on PC, and probably also through
activation of endogenous phosphatidylinositol-specific phospholipase C (PI-PLC) [29], whereas sheep
erythrocytes which contain only traces of PC are affected by CPA mainly by activation of the SM
metabolism via GTP-BPs [20,30]. In rabbit neutrophils and DonQ cells, CPA-induced superoxide anion
generation occurs through the activation of endogenous phospholipase C (PLC) and phosphorylation
of PI3K via TrkA receptor, and further phosphorylation of PDK1, PKCθ, the MEK1/2, ERK1/2 system
and NF-κB [31,32]. This pathway is also important in the generation of IL-8 by A549 cells, in addition to
the activation of p38 MAPK, which is believed to stabilize IL-8 mRNA [21]. In this regard, the sc rcity of
neutrophils wi hin gas gangrene-affected tissues and their accumulation on the vascular e othelium
could be due, at l ast in part, to th effect of elev ted IL-8 promoting firm adhesion of eutrophils
to extracellular matrix proteins [21]. Recent studies have also reported impaired differentiation and
replenishment of neutrophils in peripheral blood induced by CPA [33], effects that have been attributed
to alterations in GM1a-containing lipid rafts in those cells [34]. Furthermore, the persistence of an
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anaerobic microenvironment during gas gangrene is believed to be the result of CPA-induced activation
of arachidonic acid (AA) metabolism through phospholipase A2 (PLA2), generating prostaglandins,
tromboxanes and leukotriens, which are associated with inflammation, muscle contraction, platelet
aggregation and vasoconstriction, resulting in decreased perfusion [12].
2.3. Mechanisms of Cell Death
Lytic concentrations of CPA can result in extensive degradation of plasma membrane and lactate
dehydrogenase (LDH) release [22,35], which is characteristic of necrosis [36]. Sub-lytic concentrations
of CPA are associated with activation of the MEK/ERK pathway and generation of reactive oxygen
species (ROS) [23], which in certain amounts can lead to oxidative stress in cells and activate
intrinsic mechanisms of apoptosis [37]. A recent study [24] suggests that the SM metabolism
induced by a low CPA dose is associated with the generation of pro-apoptotic mediators, such as
CER, N-acylethanolamine and saturated fatty acids, and the release of mitochondrial cytochrome
C, activation of caspase-3 and increased exposure of phosphatidylserine in GM95 cells. The role of
CER as a second messenger involved in apoptosis has been previously described [38,39]. CER is
processed to sphingosine (SPH) which can accumulate inside of and induce rupture of lysosomes,
releasing lysosomal proteases involved in apoptosis [40]. ROS production can also lead to lysosomal
damage [41] when CPA is endocytosed through cholesterol-containing caveolae and, within endosomal
compartments, it activates signaling pathways along its trafficking routes [32]. High levels of
intracytoplasmic Ca2+ (iCa2+) commonly play a role in pre-lethal events of both apoptosis and
necrosis [42,43]. CPA leads to the formation of sphingosine-1-phosphate (S1P) from sphingosine
(SPH) [30], and inositol trisphosphate (IP3) from PIP2 [12] (Figure 1); both S1P and IP3 are associated
with mobilization and increase of iCa2+ [44]. To our knowledge, however, the role of iCa2+ as a trigger
for specific cell death pathways associated with CPA has not been investigated.
3. C. perfringens Beta Toxin (CPB)
3.1. Toxin Genetics, Structure and Role in Disease
The cpb gene is carried on large virulence plasmids which can contain additional toxin genes such
as cpe or the toxin perfringens Large (tpeL) [45,46]. CPB is encoded as a prototoxin of 336 amino acids,
including a 27-amino acid signal sequence which is removed during secretion, resulting in a mature
toxin of ~35 kDa [47,48]. The deduced amino acid sequence of CPB shares significant homology with
delta toxin and beta-pore forming toxins (β-PFTs) of Staphylococcus aureus [47]. CPB is classified as a
clostridial β-PFT of the α-hemolysin family [49], and it is characterized for being extremely sensitive
to trypsin and other proteases [50]. Due to this trypsin sensitivity, CPB is only active in the presence of
trypsin inhibitors, both in vitro and in vivo [4]. CPB variants exist that may possess different trypsin
sensitivity and in vitro cytotoxic activity [51].
CPB is produced by C. perfringens types B and C and it is responsible for diseases in several animal
species and humans [1]. Type B isolates have been associated with fatal hemorrhagic dysentery in
sheep, whereas type C isolates cause necrotic enteritis and/or enterotoxemias in several livestock
species, and enteritis necroticans (Pigbel) in humans [1,4,52]. Studies using isogenic-null mutants
demonstrated that CPB is necessary and sufficient to reproduce the intestinal pathology of type C
isolates in rabbit intestinal loops [53,54], and in goats, which are natural hosts for C. perfringens type C
disease [55]. CPB was also shown to be responsible for lethality in a mouse enterotoxemia model [56].
3.2. General Mechanism of Action
The pathology of the spontaneous disease associated with CPB is characterized by hemorrhage
and necrosis of the epithelium of the small and sometimes large intestine. CPB-associated damage
begins in the intestinal mucosa but may progress to all layers of the intestine. Fibrin thrombi occluding
the superficial microvasculature present in the lamina propria are characteristic of CPB-associated
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intestinal disease [4]. Whether the mucosal epithelium is the primary target for the toxin to induce
damage or if this is secondary to vascular thrombosis has been a frequent matter of debate. In the rabbit
intestinal loop model, inoculation of the wild-type C. perfringens type C isolate CN3685 produced
necrosis of the villous tip before thrombosis was apparent, suggesting early intestinal epithelial
injury [53]. On the other hand, CPB was demonstrated by immunohistochemistry only in endothelial
cells within the lamina propria in naturally-occurring cases of necrotic enteritis in piglets [57] and in a
human patient [58], as well as in an experimental infection model in pigs associated with early vascular
lesions [59]. In all those studies, however, tissue necrosis was already present and CPB binding to
epithelial cells was not detected. Further CPB immunohistochemical studies on porcine jejunal explants
showed no binding of the toxin to epithelial cells, and the presence of an intact epithelial layer inhibited
CPB detection into deeper intestinal layers of the intestine [60]. The same study showed no cytopathic
effect in cultured intestinal porcine epithelial cells (IPEC-J2) and primary jejunal epithelial cells when
co-incubated with recombinant CPB (rCPB). An initial epithelial damage was proposed for CPB to
reach the microvasculature in the lamina propria in the porcine intestinal model. However, since the
supernatants of two C. perfringens type C strains induced IPEC-J2 cell damage that was not prevented
with anti-CPB antibodies, it was concluded that CPB was not responsible for the cytopathic effect
observed [60]. In addition, an indirect vascular effect of CPB in mouse skin was observed, in which the
toxin induced the release of substance P (SP), an NK1 agonist from sensory neurons, leading to the
release of TNF-α and plasma extravasation [61,62].
As an oligomerizing, pore-forming toxin, CPB is capable of forming functional pores in plasma
membranes of susceptible cells [63,64]. These pores allow the efflux of K+ and the entry of Ca2+, Na+
and Cl− into the cells, followed by cell swelling [64]. Potassium efflux induced by CPB promotes
phosphorylation of p38 MAP and JNK kinases, which activate pathways associated with host cell
survival and adaptation [65]. Susceptibility of cells to CPB action has been tested in different
human hematopoietic tumor cell lines, with THP-1 and U937 cells showing the highest CPB-induced
cytotoxicity compared to HL-60, BALL-1 and MOLT-4 [65]. Using primary porcine aortic endothelial
cells, CPB was demonstrated to induce rapid disruption of the actin cytoskeleton, cell border retraction
and cell shrinkage [66]. Differences in cell susceptibility clearly suggest that the toxin binds to specific
receptors. It has been recently shown that CPB putatively binds to the ATP-gated P2X7 receptor,
after which ATP is released from the cell through an ATP channel called Pannexin 1 (Panx1) [67,68].
How this ATP release related to CPB binding occurs is not known; however, it is not associated with
cell lysis [68]. Perhaps, an initial influx of Ca2+ through the CPB pores could induce mitochondrial
ATP production and later release from the affected cell [69]. It is presumed that this rapid peak of ATP
release from cells through Panx1 could stimulate further CPB oligomer formation and consequent
cytotoxicity (Figure 2) [68]. Functional and physical interactions of Panx1 with P2X7 receptor bound
to CPB would influence Panx1 channels opening promoting ATP release [68]. Both enterocytes and
endothelial cells express the P2X7 receptor and Panx1 [70,71], but their role in CPB-associated disease
in vivo needs further investigation.
3.3. Mechanisms of Cell Death
Studies using porcine endothelial cells in vitro have shown that rCPB rapidly induces cellular
events consistent with necrosis, including LDH release and propidium iodide (PI) intake [72].
Both events were inhibited by calpain inhibitors and necrostatin-1, a RIP-1 inhibitor, which suggested
that CPB-induced necrotic cell death was not a passive event but occurred through a programmed
biochemical pathway. The authors concluded their necrostatin effects indicated CPB induces
necroptosis. However, it is worth mentioning that RIP-1 (the necrostain target) can also be involved
in apoptosis [73]. On the other hand, the referred study detected low levels of caspase-3 activation,
but not appreciable DNA fragmentation, suggesting that apoptosis was not an important cell death
pathway at the toxin concentrations and times of incubation tested. How caspase-3 activation occurred
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in those cells was not explored. It may be hypothesized that the rise of iCa2+ could play a key role since
it has been associated with both apoptosis and necroptosis through the activation of calpains [8,43].
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ETX, the third most potent clostridial toxin known after C. botulinum and C. tetani toxins,
is synthesized by strains of C. perfringens types B and D. ETX-producing C. perfringens type D strains are
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the most common cause of clostridial enterotoxemia in sheep, goats and less frequently cattle [4,80,81].
Studies using isogenic C. perfringens etx -null mutants in sheep, goats and mice models have confirmed
that ETX is the main virulence factor responsible for all lesions and symptoms due to C. perfringens
type D enterotoxemia [82,83]. Because enterotoxemia results from toxin absorption from the gut into
the circulation, toxoid vaccines are used to protect livestock against type D infections [84].
4.2. General Mechanism of Action
ETX is produced in the intestine, and even though fibrinonecrotic colitis may be present in cases
of caprine enterotoxemia, the toxin mainly targets distant organs such as the central nervous system,
lungs and heart [4]. It is believed that ETX increases intestinal permeability, hence facilitating its own
absorption [4,84]. This effect is not fully understood, but it involves the opening of the mucosa tight
junctions and degenerative changes in the lamina propria of the gut [85]. Microscopically, lesions in
the brain tend to be multifocal and characterized by perivascular and intramural vascular edema,
hemorrhage, and in more chronic cases, necrosis of the white matter and swelling of astrocytes and
axons [4]. The latter is commonly symmetrical and bilateral [86]. The origin of these lesions is believed
to be the result of an initial binding of the toxin to endothelial cells of the brain–blood barrier (BBB)
since intravenous inoculation of ETX labeled with green-fluorescent protein (GFP) in mice revealed
binding of the toxin to those cells [87]. After ETX binding, endothelial cells become swollen, vacuolated
and necrotic [88]. By disrupting the BBB, leakage of fluids and proteins occurs, leading to an edema
that causes mechanical damage and hypoxia of the neural parenchyma [83]. In response to this edema,
astrocytes of rats and sheep overexpress aquaporin-4, which is believed to be the host’s attempt to
reduce the excess of fluid from perivascular spaces [83,89]. In addition to this indirect effect on the
brain, ETX can directly affect certain types of neurons and oligodendrocytes, but not astrocytes [90–92].
Mice injected with ETX fused to GFP also revealed severe kidney alterations, including degeneration
of distal tubules and hemorrhages in the medulla [93]. However, renal lesions are not usually observed
in natural disease and the so-called “pulpy kidney” is believed to be a postmortem change rather than
a true lesion [84].
Binding and cytotoxic activities of ETX have been extensively studied using cell lines from renal
origin of different species in which spontaneous cases of type D enterotoxemia have not been reported,
including dogs (Madin–Darby canine kidney cells, MDCK), mice and humans. However, kidney cell
lines from species naturally affected by ETX such as sheep and cattle are resistant [94].
The initial steps of ETX action involve binding to an unidentified cell surface receptor and
heptamerization into a prepore on the membrane surface, followed by insertion into the plasma
membrane to form an active pore [95–97]. Recently, it was reported that ETX activates neutral
sphingomyelinase (nSMase) which in turn facilitates oligomer formation by producing ceramide in the
plasma membrane [98]. In fact, knockdown of nSMase blocked oligomer formation and ETX-induced
cell death in ACHN cells (derived from human renal adenocarcinoma) (Figure 3) [98]. Since that
particular study used ETX isolated from C. perfringens culture, it is possible that impurities containing
CPA, which also induces CER formation [24], could have been in part responsible for this effect,
which might indicate a synergistic effect between these two toxins. This possibility, however, has not
been explored. In vitro, ETX binds to the hepatitis A virus cellular receptor (HAVCR1) in MDCK
and ACHN cells, facilitating cytotoxicity [99]. Nevertheless, induced expression of HAVCR1 in cells
resistant to ETX did not result in sensitivity to the toxin [99]. The myelin and lymphocyte (MAL) protein
has been found to be required for ETX cytotoxicity in several cell types [100]. MAL is expressed in
many cells known to be targeted by ETX, including endothelial cells, renal cells and oligodendrocytes.
Neurons, which have been suggested but not definitively proved to be sensitive to ETX, do not
express MAL [101]. It has been hypothesized that MAL may act as a specific receptor for ETX, as a
protein involved in assembly of a multi-protein complex required for ETX interaction with the plasma
membrane, or even allowing a mechanism independent of pore formation [100,102].
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4.3. Mechanisms of Cell Death
Mechanisms of cell death and intracellular pathways associated with ETX action are not fully
characterized. However, the toxin induces cellular changes that are compatible with necrosis,
including initial and marked cell swelling, followed by disappearance of mitochondria, blebbing,
membrane disruption, ATP depletion, reduction of nucleus size and increased PI uptake; no DNA
fragmentation occurs [81,103,104]. Pore formation in affected cells leads to a rapid loss of intracellular
K+, entry of Cl− and Na+, followed later by an increase of iCa2+ [103]. Whether this imbalance
of intracellular electrolytes is involved in activating specific downstream signaling events leading
to cell death has not been determined, although it seems likely. ETX-affected cells lose important
coenzymes critical for energy production, particularly nicotinamide adenine dinucleotide (NAD+ and
NADH) and coenzyme A, contributing to the dissipation of the mitochondrial membrane potential
and opening of the mitochondrial permeability transition pore [104,105]. Consistent with those
findings, AMP-activated protein kinase, an intracellular sensor of ATP, is stimulated in ETX-affected
cells [104]. In addition, apoptosis-inducing factor (AIF), a potent caspase-independent cell death
factor, is translocated from mitochondria to the nucleus (Figure 3) [104]. Paracellular permeability
to macromolecules is not significantly increased in renal cells treated with ETX in vitro, and actin
cytoskeleton and organization of tight and adherens junctions are not affected [104,106]. In the brain,
ETX can bind to certain types of neurons and cause a decrease in electrical membrane resistance [104],
which is attributed to pore formation. This induces membrane depolarization associated with an
increase of iCa2+, followed by the release of the excitatory neurotransmitter, glutamate [92,107].
Interestingly, ETX does not form pores in the plasma membrane of oligodendrocytes [92]; thus, the
associated glutamate release, Ca2+ fluctuations and demyelination occurs by a different mechanism,
involving intracellular pathways occurring as a consequence of ETX–MAL interaction [92,102].
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Figure 3. Pathways involved in C. perfringens epsilon-toxin (ETX) intracellular action. ETX (PDB ID:
1UYJ) action involves binding to its receptor (ETX-r), such as the myelin and lymphocyte (MAL) protein.
Neutral sphingomyelinase (nSMase) may be activated resulting in sphingomyelin (SM) hydrolysis and
ceramide (CER) production, which would facilitate ETX oligomer formation. Oligomerization results in
a heptameric pore that induces a rapid loss of iK+, entry of Cl− and Na+ (not shown), followed later by
an increase of iCa2+. ETX-affected cells also lose important coenzymes required for energy production,
including NAD+, NADH and CoA, contributing the formation of the mitochondrial permeability
transition pore (MPTP). This would facilitate the translocation of the apoptosis-inducing factor (AIF),
a caspase independent cell death factor, from mitochondria to the nucleus. Dashed red arrows represent
what is concluded and/or suggested by the current authors. A dashed black arrow shows direction
of movement.
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5. C. perfringens Iota Toxin (ITX)
5.1. Toxin Genetics, Structure and Role in Disease
ITX is a clostridial binary toxin composed of an enzyme component (Ia) and a binding component
(Ib) (Figure 4) [108]. Both components are encoded by two separate genes, iap and iab, which are
located on large, potentially conjugative plasmids [109]. Ib is synthetized as an inactive form (100 kDa)
which becomes active after proteolytic removal of a 20 kDa N-terminal fragment by trypsin or
chymotrypsin [110].
ITX is produced by C. perfringens type E strains. Enteric disease associated with this toxinotype
has been suggested in many animal species. However, the diagnosis in most of those cases was based
only on isolation of C. perfringens type E from intestinal content of animals with hemorrhagic enteritis,
which is not considered to be a diagnostic criterion for C. perfringens type E infection. In addition,
Koch’s molecular postulates have not been fulfilled for type E disease. The specific role of ITX in
disease remains, therefore, unclear [111]. In the past, cases of enterotoxemia in rabbits were attributed
to C. perfringens type E, based on the detection of ITX in the intestine of affected animals. Nevertheless,
it has been hypothesized that those cases were probably caused by an iota-like toxin produced by
Clostridium spiroforme, a toxin that cross-reacts with ITX by currently available toxin detection methods.
To date, there are no reliable diagnostic criteria or gold standards for the diagnosis of C. perfringens
type E-associated disease in animals [4,111].
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Figure 4. Intracellular pathways involved in C. perfringens iota-toxin (ITX) action. ITX is a binary
toxin composed of an enzyme component (Ia) and a binding component (Ib). The lipolysis-stimulated
lipoprotein receptor (LSR) has been reported a cellular receptor for Ib; after binding, Ib oligomerizes in
a heptameric, functional pore that allows the movement of ions, and the translocation of Ia. Cytotoxicity
involves features of necrosis, including decreased ATP, increased cell permeability and cell swelling.
Bak and Bax activation also occurs leading to cytochrome C release from mitochondria. In addition,
both Ia and Ib are internalize in endosomes. While a small proportion of Ib is recycled back to the plasma
membrane, Ia is translocated into the cytoplasm from late endosomes. Once in the cytoplasm, Ia exerts
its ADP-ribosylating activity, leading to depolymerization of actin which results i morphologic
changes. Cytosolic stability of Ia would induce, likely via depolymerization of actin, a delayed caspase-3
ctivation and apoptosis. A dashed red arrow represents what is concluded and/or suggested by the
current a thors. A dashed black rrow hows dir ction of m vement.
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5.2. General Mechanism of Action
The lipolysis-stimulated lipoprotein receptor (LSR) has been reported as a cellular receptor for Ib,
which also mediates the toxin entering into host cells [112]. It has also been shown that entrance of
ITX into host cells can involve cell-surface antigen CD44-associated endocytosis [113]. Once bound
to its receptor, Ib assembles into heptamers which insert into the host plasma membrane forming
functional channels, allowing the movement of ions, and the translocation and endocytosis of Ia
(Figure 4) [114–117]. The enzymatic Ia component is also secreted as an inactive form that needs
proteolytic removal of 9 to 11 N-terminal residues [110]. The Ia C-domain is responsible for the
ADP-ribosylating activity of the toxin, which involves the covalent attachment of ADP-ribose onto an
Arg at residue 177 of actin [118]. This leads to the depolymerization of actin filaments and increase
of G-actin monomers [118,119]. Depolymerization of the actin cytoskeleton results in changes in cell
morphology and disorganization of intercellular tight and basolateral junctions, leading to an increase
permeability of cultured monolayers of intestinal cells [114]. Both ITX components internalize in
targeted cells via a Rho-dependent, clathrin-independent pathway and reach endocytic vesicles [120].
A small proportion of Ib is recycled back to the plasma membrane, enhancing further uptake of
Ia [121]. After endocytosis, Ia translocates from late endosomes into the cytoplasm where it exerts its
ADP-ribosylating activity (Figure 4). This translocation requires the acidic environment present in late
endosomes [122].
5.3. Mechanisms of Cell Death
It has been demonstrated that Ib by itself can induce cytotoxic activity, particularly in two human
cell lines, namely A431 (epithelial carcinoma) and A549 (lung adenocarcinoma) [123]. Those cytotoxic
effects involved marked cell swelling, mitochondrial dysfunction, ATP depletion and increased IP
intake, all features consistent with necrosis. Even though activation of the pro-apoptotic molecules
Bax and Bak and cytochrome C release was also observed, no activation of caspase-3 was detected
and incubation of cells with the pan-caspase inhibitor Z-VAD-FMK did not protect cells from
Ib-induced loss of viability. In that study, internalization of Ib was indicated as required for cell
survival, suggesting a role for endocytosis in protecting cells against pore formation associated with Ib.
In another study, however, ITX treatment of Vero cells induced caspase-3 activation after 12 to 15 h of
incubation [124]. This delayed induction of apoptotic cell death was attributed to the cytosolic stability
of the ADP-ribosylating Ia targeting actin (Figure 4).
6. C. perfringens Enterotoxin (CPE)
6.1. Toxin Genetics, Structure and Role in Disease
The cpe gene can be positioned on either the chromosome or on plasmids, and the expression of
the toxin only occurs during sporulation [125,126]. CPE consists of a single polypeptide containing
319 amino acids [127]. The C-terminal half of the toxin lacks cytotoxic activity, but it mediates receptor
binding, which involves the presence of several tyrosine residues located on the last 30 amino acids of
CPE [128–130]. On the other hand, the N-terminal half is particularly important for cytotoxicity given
its key role in CPE oligomerization and pore formation [131].
CPE is a pore-forming toxin produced during sporulation mainly by strains of C. perfringens type
F [3] (Table 1), formerly known as CPE+ type A strains. However, CPE-producing strains belonging to
C and D toxinotypes are also common [132]. Type E strains can carry a silent cpe gene [133] or produce
a variant CPE [134]. Experimental and epidemiological evidence indicates CPE as the main virulence
factor involved in C. perfringens type F-associated food poisoning of humans [125,127]. Molecular
Koch’s postulates have been fulfilled in rabbits for CPE-producing type F strains [135]. C. perfringens
type F strains are also involved in about 5–10% of all cases of antibiotic-associated diarrhea [136].
Symptoms of CPE-associated food poisoning include diarrhea and abdominal cramps, and they usually
resolve spontaneously after a day or two [125]. However, under certain predisposing conditions,
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including constipation or fecal impaction, CPE can be lethal. It is thought that by reducing the effect
of diarrhea in those situations, the toxin would prolong its contact with the intestine, facilitating the
absorption and action on extra-intestinal organs [137,138]. This enterotoxemic effect is supported by
studies performed in mouse-ligated intestinal loops, in which the inoculated CPE gained access to the
circulation and caused hyperpotassemia resulting in death [139].
6.2. General Mechanism of Action
The cellular action of CPE has been previously described in detail [127]. The cellular receptors
for CPE are several members of the claudin family, essential components of tight junctions located
at the apical contact region between epithelial and endothelial cells [127]. Specifically, claudins 3, 4,
6, 8, and 14 are proven CPE receptors [140–142]. Initial binding of CPE to claudin receptors results
in the formation of a “small complex” of ~90 kDa [143]. The interaction of several (about 6) of these
small complexes leads to CPE oligomerization and formation of a prepore on the plasma membrane
surface [144]. The result is a “large complex” of ~450 kDa, named CH-1, which contains the CPE
hexamer, receptor and non-receptor claudins [143]. The formation of a cation-permeating pore is
initiated by the assembly of β-hairpin loops from CPE into a β-barrel that rapidly inserts into the
plasma membrane of the target cell [145]. This CPE pore allows the influx of calcium which is essential
for CPE to cause cell death (Figure 5 [146–148]).
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6.3. Mechanisms of Cell Death
When enterocyte-like Caco-2 cells are exposed to low CPE doses, a low number of pores are
formed and a modest influx of calcium follows, resulting in low calpain activation and apoptosis,
characterized by cytochrome C release and caspase-3 activation [148,149]. However, with higher
CPE doses, the formation of many pores results in massive influx of calcium and strong calpain
activation, leading to minimal caspase-3 activation and morphologic cellular changes consistent with
necrosis [149]. Extended incubation times in vitro intensify those morphological changes, resulting in
the exposure of the basolateral cell surface; this allows additional binding of CPE and the formation of
an even larger complex of ~600 kDa named CH-2 that contains claudin and occludin proteins [143,150].
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In small intestinal-loops made in mice and rabbits, CPE induced dose-dependent histologic damage
characterized by severe villous shortening, desquamation, and changes in epithelial cells consistent
with necrosis (e.g., pyknosis, karyorrhexis) [139,151]. Histologic damage also occurs in the rabbit
colon [152]. In contrast to the in vitro findings previously commented, treatment of mice intestinal
loops with CPE induced a dose- and time- dependent caspase-3 activation [153]. This activation,
however, was not essential for the development of intestinal lesions, because the use of the pan-caspase
inhibitor Q-VD-OPh did not protect from intestinal damage or enterotoxemic death [153]. The role
of calpain activation and a potential involvement of necroptosis in CPE-associated disease have not
been explored.
7. C. perfringens Necrotic Enteritis B-Like Toxin (NetB)
7.1. Toxin Genetics, Structure and Role in Disease
The netB gene is located on a 42 kb pathogenicity locus named NELoc1, present on large,
conjugative plasmids [154–157]. Like CPB, NetB shares partial sequence similarity with a β-PFT,
named alpha hemolysin, from S. aureus [158].
According to the updated toxinotyping scheme, NetB is produced by C. perfringens type G
strains (Table 1) [3]. Molecular Koch’s postulates for this toxin have been fulfilled in chicken
disease models [159]. Those studies confirmed that NetB is the primary virulence factor involved
in the development of avian necrotic enteritis, which is also supported by strong epidemiological
evidence [159–161].
7.2. General Mechanism of Action
Death of enterocytes in cases of avian necrotic enteritis has been described as a consequence of
an initial destruction of the lamina propria, the extracellular matrix and intercellular junctions [162].
NetB forms heptameric, hydrophilic pores with a central diameter of approximately 26 Å [163].
The specific receptor for NetB, however, has not been identified [161].
7.3. Mechanisms of Cell Death
As for many other pore-forming toxins, NetB pores allow an influx of ions such as Na+, Cl−
and Ca2+ that may lead to osmotic cell lysis [160]. The toxin induces rounding and lysis of LMH
cells, with subsequent LDH release [160]; although this is consistent with features of necrosis, specific
pathways involved in cell death, to our knowledge, have not been explored for NetB action on
the intestine.
8. Concluding Remarks
The body of knowledge about the molecular mechanisms of action of the main C. perfringens
toxins has increased significantly over the past few years. It is interesting to observe, for example,
how the hemolytic activity of CPA varies according to the affected host (horse vs sheep), and how
ETX may induce intestinal lesions in goats in some cases of enterotoxemia, but rarely in other
species. Host and cell susceptibility seem to be key elements for consideration when studying
the pathogenesis of C. perfringens infections, and therefore the selection of either in vitro or animal
models for C. perfringens-associated disease should address these variations. Since most C. perfringens
toxins bind to and act on a receptor located on the plasma membrane of the host cell, this early step
in the pathogenesis represents an evident therapeutic target for treating C. perfringens-associated
diseases. In this regard, for instance, the therapeutic agent Mepacrine has been shown to protect
enterocyte-like cells against CPE action in vitro by interfering with pore formation and insertion [164].
The potential effect of Mepacrine against CPE is currently being investigated in a mouse model.
The final consequence in the action of most C. perfringens toxins is cell death. In the past few years
significant progress has been made in understanding the complex intracellular pathways involved in
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this outcome by using different approaches. However, there are still many gaps in this knowledge,
and dissecting the complex interaction between C. perfringens toxins and target cells may lead to the
identification of additional pharmacological targets.
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